CAMC Urology is the first in West Virginia to offer a new, minimally-invasive treatment option for men with benign prostatic hyperplasia (BPH), which is an enlargement of the prostate gland – the most common prostate problem in men 50 and older.
Rezum® is an FDA-approved treatment that injects small amounts of steam directly into the prostate, killing some of the benign tissue. The gland then shrinks as it repairs itself, relieving men of symptoms caused by the enlarged prostate, which include the need to urinate more frequently and with more urgency (especially at night), irregular flow and straining to urinate.
“Rezum® offers many advantages over traditional treatments for BPH,” said Nathan Hale, DO, urologist at CAMC. “The ability to target the extra tissue that needs to be removed while sparing the tissue around the prostate, with very few side effects, is what makes this procedure different and effective.”
Hale said advantages of this innovative procedure are that it can free men from taking daily medications, it doesn’t require major surgery, and it allows men to retain normal sexual function, unlike some existing treatments.
“Candidates for this procedure are men who have been on medication and are no longer finding it to be effective,” Hale said. “It’s also an option for men who don’t want to commit themselves to a lifetime of taking medications or who don’t want to deal with the side effects that they’re experiencing with medications.”
Rezum® is performed under twilight anesthesia (a mild dose of general anesthesia). It does not require an overnight hospital stay, and most men return to normal activities within a few days. Patients often notice significant improvement in their symptoms within two weeks.
Hale says Rezum® could be a game-changer for managing BPH.
“Other minimally-invasive treatments have come and gone, but they have not been able to provide the lasting effects that we think Rezum® will provide,” Hale said.
Call us for more information at (304) 388-1900.